em 523 has been researched along with acetaminophen in 1 studies
| Studies (em 523) | Trials (em 523) | Recent Studies (post-2010) (em 523) | Studies (acetaminophen) | Trials (acetaminophen) | Recent Studies (post-2010) (acetaminophen) |
|---|---|---|---|---|---|
| 26 | 1 | 0 | 20,696 | 2,848 | 8,242 |
| Protein | Taxonomy | em 523 (IC50) | acetaminophen (IC50) |
|---|---|---|---|
| Myoglobin | Homo sapiens (human) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, T; Ishii, M; Kasai, F; Nakamura, T; Takebe, K | 1 |
1 trial(s) available for em 523 and acetaminophen
| Article | Year |
|---|---|
Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Biomarkers; Diabetes Mellitus, Type 1; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Male; Middle Aged; Postprandial Period; Time Factors | 1997 |